Synonyms: Example 3 [WO2010021918]
Compound class:
Synthetic organic
Comment: Veonetinib is the INN for a tyrosine kinase inhibitor from WHO proposed INN list 131 (August 2024). This is a racemic mixture of optical isomers. We show the structure without stereo-specificity to represent the racemate. The structure for veonetinib is claimed as Example 3 in patent WO2010021918 (Advenchen Laboratories) [1]. There is no information in this patent regarding the specific kinase(s) inhibited (just experimental evidence of antiproliferative activity against lung and colon cancer cell lines).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
5-[2-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxyethyl]-5-azaspiro[2.4]heptan-7-ol |
International Nonproprietary Names ![]() |
|
INN number | INN |
13085 | veonetinib |
Synonyms ![]() |
Example 3 [WO2010021918] |
Database Links ![]() |
|
CAS Registry No. | 1210828-09-3 (source: WHO INN list) |
GtoPdb PubChem SID | 500839903 |
PubChem CID | 46176482 |
Search Google for chemical match using the InChIKey | RYPUFHJIOUAMKT-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | RYPUFHJIOUAMKT |
Search PubMed clinical trials | veonetinib |
Search PubMed titles | veonetinib |
Search PubMed titles/abstracts | veonetinib |
UniChem Compound Search for chemical match using the InChIKey | RYPUFHJIOUAMKT-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RYPUFHJIOUAMKT-UHFFFAOYSA-N |